Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Cipta Sarana Medika Tbk. (DKHH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Cipta Sarana Medika Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 14.05M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Cipta Sarana Medika Tbk. is more actively traded (14.05M versus 41.7K). Which is the better fit depends on your goals.
| DGNS | DKHH | |
|---|---|---|
Market Cap | 316.25B | 160.67B |
Volume | 41.7K | 14.05M |
Lot | 417 | 140.49K |
Turnover | 9.66M | 899.67M |
Average Price | 231.65 | 64.04 |
Value | 9.66M | 899.67M |
Indicative Equilibrium Price | 230 | 64 |
Indicative Equilibrium Volume | 2.4K | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →
